Abstract Body

We aimed to identify an HIV-related microbiota signature, independent of sexual preferences and demographic confounders, to assess a possible impact of the microbiome on metabolic comorbidities.

405 HIV-infected and 111 uninfected individuals, stratified to sexual behaviour (men who have sex with men, MSM and non-MSM), were included from the COCOMO study. Stool samples were analyzed using 16S rRNA sequencing. Hypotheses were tested using regression models adjusting for known confounders.

Microbiota alterations in HIV-positive MSM and uninfected MSM were largely overlapping. After filtering out MSM-associated microbiota traits and adjusting for relevant confounders, we identified an HIV-related dysbiosis, consisting of lower biodiversity, increased relative abundance of Gammaproteobacteria and Desulfovibrionaceae and decrease in several Clostridia (Figure 1). HIV-related dysbiosis was associated with previous immunodeficiency (low nadir CD4), elevated microbial translocation markers (soluble CD14 and LPS-binding protein, p<0.05), and a 2-fold (adjusted Odds Ratio (aOR) 1.97 [1.12; 3.46]) increased excess risk of metabolic syndrome, the latter driven by increase in Desulfovibrionaceae and decrease in several Clostridia of the Lachnospiraceae and Ruminococcaceae families (Butyrivibrio, Coprococcus-2, Lachnospiraceae UCG-001 and CAG-56). In individuals with a history of AIDS, this microbiota profile was associated with 8-fold (aOR 8.14 [1.74; 38.07]) excess risk of metabolic syndrome and 6-fold (aOR 6.71 [1.35; 33.50]) excess risk of abdominal obesity.

HIV infection was associated with altered bacterial composition, independently of sexual behaviour and demographic factors. HIV-related dysbiosis was associated with increased risk of metabolic syndrome, particularly in individuals with previous severe immunodeficiency. The excess metabolic risk was driven by increased Desulfovibrionaceae, H2S-producing bacteria with toxic effects on the gut epithelium, and decrease of potentially butyrate-producing Clostridia. As outgrowth of Desulfovibrio and reduction in Clostridia have been shown to trigger metabolic alterations in immunodeficient mice, our findings suggest a potential interplay between HIV-related dysbiosis, previous immunodeficiency and future risk of metabolic comorbidities.